Medicamen Biotech Limited (NSE:MEDICAMEQ)

Market Cap	3.29B -47.5%
Revenue (ttm)	1.72B -4.5%
Net Income	77.66M +5.3%
EPS	5.84 -4.0%
Shares Out	n/a
PE Ratio	42.40
Forward PE	n/a
Dividend	1.00 (0.40%)
Ex-Dividend Date	Sep 19, 2025

Volume	67,394
Average Volume	32,842
Open	262.50
Previous Close	258.10
Day's Range	259.95 - 284.60
52-Week Range	216.95 - 457.15
Beta	0.57
RSI	50.61
Earnings Date	May 29, 2026

About Medicamen Biotech

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 376
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICAMEQ

Financial Performance

In fiscal year 2025, Medicamen Biotech's revenue was 1.68 billion, a decrease of -6.56% compared to the previous year's 1.79 billion. Earnings were 71.08 million, a decrease of -34.97%.